View SAPRP grants by type:

View SAPRP grants by:
Topic
,
Date or Investigator r

 

Cost of Treatment Grants

Grants listed by date, with most recent appearing first. Click a grant title for detailed information, including a summary and publications.

The Adoption of Pharmaceutical Technologies in Addiction Treatment, Carolyn Heinrich, Ph.D.
Medicaid and Public Funding for Buprenorphine Treatment of Opioid Dependence, David Fiellin, M.D.
Reducing or Expanding Substance Use Disorder Treatment Programs: Evaluating Impact from the Health Care Decision-Maker's Perspective, Keith Humphreys, Ph.D.
Understanding the Impacts of Funding Volatility on Treatment Services, Patricia Ebener,
Effects of Reductions in Oregon Health Plan Coverage of Substance Abuse and Mental Health Services on Its Most Vulnerable Citizens, Roy Gabriel, Ph.D.
Cost Analysis and Operations Assessment of Community-based Alcohol and Drug Treatment Program, Yih-Ing Hser, Ph.D.
Translating Alcohol Intervention Research into Clinical Trauma Centers, Carol Schermer, M.D., M.P.H.
Public Financing and Treatment for Dual Disorders: A Case Study, Robin Clark, Ph.D.
Costs and Benefits of Prison-Based Treatment Plus Aftercare Drug-Abusing Offenders, Kathryn McCollister, Ph.D.
A Follow-up Study of Medicaid Chemical Dependency Patients in a Private HMO: Do High Medical Costs Come Down over Time?, Lawrence Walter, M.A.
The Sensitivity of Drug Abuse Treatment Demand to Copayment Levels, Anthony Lo Sasso, Ph.D.
Integrated versus Referred Out Methadone Treatment: Quality and Costs, Daniel Polsky, Ph.D.
Cost Effectiveness of Prenatal/postnatal Treatment/interventions for Drug Abusing Pregnant Women, Jean Bailey, Ph.D.
Comparison of Utilization and Costs of Medicaid and non-Medicaid Chemical Dependency Patients in a Group Model HMO, Lawrence Walter, M.A.
Developing a Foundation for Outcome Based Purchasing of Addictions Treatment, Norman Hoffmann, Ph.D.
Analysis of the Cost Effectiveness of Correctional Substance Abuse Treatment Programs, Craig Love, Ph.D.
Differential Outcome and Cost-benefit Parameters of a Statewide Drug Abuse Treatment System, M. Douglas Anglin, Ph.D.
 
   
 
 
     
   
  About SAPRP  | SAPRP Staff | Questions | P: 336.286.4548 | F: 336.286.4550 

SAPRP . One Leadership Place . Greensboro, NC 27410 . saprp@ccl.org